Prescriber Resources

Key Points for Prescribers

• The prescriber enrolls and becomes certified with Lenalidomide REMS
• The prescriber counsels patient on benefits and risks of lenalidomide
• The prescriber provides contraception and emergency contraception counseling
• The prescriber verifies negative pregnancy test for all female patients of reproductive potential
• The prescriber completes a Lenalidomide REMS Patient-Physician Agreement Form with each patient and sends to Lenalidomide REMS
• The prescriber/patient completes applicable mandatory confidential survey
• The prescriber obtains an authorization number from Lenalidomide REMS and writes it on every prescription, along with the patient risk category
• The prescriber writes no more than a 4-week (28-day) supply, with no automatic refills or telephone prescriptions
• The prescriber sends lenalidomide prescription to certified pharmacy

Enrolling in Lenalidomide REMS

In order to prescribe lenalidomide, you must enroll in Lenalidomide REMS. You can enroll by visiting CelgeneRiskManagement.com, a website that allows prescribers to handle the REMS process for all of the REMS programs. You can also download the Prescriber Enrollment Form below and fax it to Lenalidomide REMS at 1-888-432-9325.

Prescriber Enrollment Form

Prescribing lenalidomide for your patients

In order to receive lenalidomide, your patients must also be enrolled in Lenalidomide REMS. You can enroll your patients and fill out a prescription form using CelgeneRiskManagement.com. You and your patients can also complete your mandatory confidential surveys there.

Enroll Your Patients at
CelgeneRiskManagement.com

Patient Prescription Form

Learning more about Lenalidomide REMS

For additional information about Lenalidomide REMS, please see the educational materials below.

Prescriber Guide to
Lenalidomide REMS

Lenalidomide REMS
At-A-Glance

Full Prescribing Information

Please report adverse drug experiences that are suspected to be associated with the use of lenalidomideand any suspected pregnancy occurring during the treatment with lenalidomide to Lenalidomide REMS using any of the following methods: